Seeking Alpha

John Putnam » Articles » HAE |

  • 2009 Outlook for Medical Device Stocks
    on Jan 16, 2009 ABT, BAX, BDX    
More on HAE by John Putnam
Articles by Ticker

Latest Comments on John Putnam's Articles

  1. carrierwave on Plavix: Winners and Losers: Most medicines nowadays are taken from cures found IN HERBAL... more »
  2. Douglas Cress on Endologix: Financially Strong, Large and Growing Market: Agreed! Love this company. Loved it more at $1.25. more »
  3. Dr.Nicky on Plavix: Winners and Losers: Autogenomics is the only company in molecular diagnostics that... more »
  4. HealthcareIT on An Increase in Healthcare M&A Doesn't Yet Signal a Bottom: MedLink is public (MLKNA.OB) more »
  5. HealthcareIT on An Increase in Healthcare M&A Doesn't Yet Signal a Bottom: In reading your article you do not discuss the M&A activity in the... more »
  6. SumoBackup on An Increase in Healthcare M&A Doesn't Yet Signal a Bottom: No matter how poor people get, they'll still pay good money for... more »
  7. Cynthia on Medtronic: Slipping Off Its Perch?: Speaking of Medronic, I just read another article about a... more »
  8. Cynthia on Medtronic: Slipping Off Its Perch?: I just read another article about how the North American Spinal... more »
  9. pdriscoll on Abbott Labs and Johnson & Johnson: Clash of the Titans: Good, sanguine comparison between these two "titans". Thanks! more »
  10. Socialism cannot compete! on Medtronic: Slipping Off Its Perch?: "Since Medtronic’s stock hit its 2008 high on August 22nd of... more »
  11. Hamburger on Plavix: Winners and Losers: Give me a break Lin, herbal medicine or natural medicine is for... more »
  12. otbricki on Plavix: Winners and Losers: Nattokinase has been implicated in cerebral hemorrhages. I would... more »
  13. Lin on Plavix: Winners and Losers: Re Plavix A much better natural alternative is a substance... more »
  14. pdriscoll on 2009 Outlook for Medical Device Stocks: Perhaps the most salient impacts of the current financial... more »
  15. Anthony Alfidi on 2009 Outlook for Medical Device Stocks: Don't forget the huge premium that Eli Lilly paid for Imclone last... more »